Lodise Thomas, Graves Jeffrey, Miller Chris, Mohr John F, Lomaestro Ben, Smith Raymond P
Albany College of Pharmacy, 106 New Scotland Avenue, Albany, NY 12208-3492, USA.
Pharmacotherapy. 2007 Nov;27(11):1498-505. doi: 10.1592/phco.27.11.1498.
To compare rates of hypoglycemia and hyperglycemia among elderly hospitalized patients with normal blood glucose concentrations at baseline who were receiving either gatifloxacin or levofloxacin, and to determine if appropriateness of their doses, according to their package inserts, was associated with hypoglycemia or hyperglycemia.
Retrospective cohort study.
Integrated Veterans Administration (VA) health care system.
Nine hundred thirty-seven elderly (>or= 65 yrs) patients with documented blood glucose levels of 65-140 mg/dl before receiving a fluoroquinolone.
Between January 2003 and April 2004, 405 patients receiving levofloxacin met study criteria. In April 2004, gatifloxacin was substituted for levofloxacin on the formulary of this VA system. Thus, between April 2004 and December 2004, 532 patients received gatifloxacin. All blood glucose concentrations during hospitalization that were measured during fluoroquinolone therapy or within 72 hours of completion of therapy were reviewed. Demographic characteristics, comorbidities, insulin and oral hypoglycemic therapies, disease severity, blood glucose levels, and outcomes were recorded and compared between groups. The two groups were similar at baseline for all characteristics examined except previous hospitalization. In the logistic regression, gatifloxacin was independently associated with both hypoglycemia (adjusted odds ratio [AOR] 2.5, 95% confidence interval [CI] 1.2-5.7, p=0.04) and hyperglycemia (AOR 2.4, 95% CI 1.5-3.6, p<0.001). Improper dosage adjustment based on renal function was not associated with higher rates of hypoglycemia and hyperglycemia for either drug. Of the 532 patients receiving gatifloxacin, 465 (87.4%) received appropriate doses, yet gatifloxacin was associated with higher rates of hypoglycemia and hyperglycemia compared with patients receiving levofloxacin.
Higher rates of both hypoglycemia and hyperglycemia were noted among elderly hospitalized patients who received gatifloxacin compared with those receiving levofloxacin, irrespective of dosing.
比较在基线血糖浓度正常的老年住院患者中,接受加替沙星或左氧氟沙星治疗时低血糖和高血糖的发生率,并根据药品说明书确定其剂量的合理性是否与低血糖或高血糖有关。
回顾性队列研究。
退伍军人事务部(VA)综合医疗保健系统。
937名年龄≥65岁的老年患者,在接受氟喹诺酮类药物治疗前血糖水平记录为65 - 140mg/dl。
2003年1月至2004年4月,405名接受左氧氟沙星治疗的患者符合研究标准。2004年4月,该VA系统的药品处方中用加替沙星替代了左氧氟沙星。因此,在2004年4月至2004年12月期间,532名患者接受了加替沙星治疗。对氟喹诺酮类药物治疗期间或治疗结束后72小时内测量的所有住院期间血糖浓度进行了回顾。记录并比较了两组患者的人口统计学特征、合并症、胰岛素和口服降糖治疗、疾病严重程度、血糖水平及结局。除既往住院史外,两组在所有检查特征的基线时相似。在逻辑回归分析中,加替沙星与低血糖(校正比值比[AOR]2.5,95%置信区间[CI]1.2 - 5.7,p = 0.04)和高血糖(AOR 2.4,95%CI 1.5 - 3.6,p < 0.001)均独立相关。两种药物基于肾功能的剂量调整不当与低血糖和高血糖的较高发生率均无关。在532名接受加替沙星治疗的患者中,465名(87.4%)接受了合适的剂量,但与接受左氧氟沙星治疗的患者相比,加替沙星与更高的低血糖和高血糖发生率相关。
与接受左氧氟沙星治疗的老年住院患者相比,接受加替沙星治疗的患者低血糖和高血糖的发生率均更高,与剂量无关。